NFKB1 and ovarian carcinoma: NF-κB pathway activity could indicate a more effective immune response, which is associated with improved survival, as the presence of CD3+ tumor-infiltrating T cells has been associated with improved clinical outcome in women with advanced-stage epithelial ovarian cancer [31].